ANEMIA PREDICTS SUSTAINED VIROLOGIC RESPONSE IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN FOUR CLINICAL TRIALS

被引：0
|
作者：
Reau, N. [1 ]
Korner, E. J. [2 ]
Han, J. [2 ]
Jensen, D. M. [1 ]
机构：
[1] Univ Chicago Hosp, Ctr Liver Dis, Chicago, IL 60637 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60894-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
892
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 50 条
  • [21] Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection
    Toyoda, Hidenori
    Kumada, Takashi
    Tada, Toshifumi
    Kiriyama, Seiki
    Tanikawa, Makoto
    Hisanaga, Yasuhiro
    Kanamori, Akira
    Kitabatake, Shusuke
    Ito, Takanori
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (07) : 1183 - 1189
  • [22] Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin
    Scherzer, Thomas-Matthias
    Hofer, Harald
    Staettermayer, Albert Friedrich
    Rutter, Karoline
    Beinhardt, Sandra
    Steindl-Munda, Petra
    Kerschner, Heidrun
    Kessler, Harald H.
    Ferenci, Peter
    JOURNAL OF HEPATOLOGY, 2011, 54 (05) : 866 - 871
  • [23] Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin
    Snoeck, Eric
    Wade, Janet R.
    Duff, Frank
    Lamb, Matthew
    Jorga, Karin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 699 - 709
  • [24] Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response
    Tseng, Chih-Wei
    Chen, Chi-Yi
    Chang, Ting-Tsung
    Tzeng, Shinn-Jia
    Hsieh, Yu-Hsi
    Hung, Tsung-Hsing
    Lee, Ching-Chih
    Wu, Shu-Fen
    Tseng, Kuo-Chih
    PLOS ONE, 2014, 9 (06):
  • [25] Is sustained virologic response durable in patients with chronic hepatitis C treated with interferon alfa with or without ribavirin?
    Cheinquer, N
    Cheinquer, H
    Coelho-Borges, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 103 - 103
  • [26] Early prediction of response to 40 kDa peginterferon alfa-2a (PEGASYS®) plus ribavirin (RBV) in patients with chronic hepatitis C (CHC).
    Ferenci, P
    Shiffman, ML
    Fried, MW
    Sulkowski, MS
    Haeussinger, D
    Zarski, JP
    Goncales, F
    Jensen, DM
    Bonino, F
    Dhumeaux, D
    Blotner, S
    Hoffman, J
    Oliveto, J
    HEPATOLOGY, 2001, 34 (04) : 351A - 351A
  • [27] Predictive factors in treatment of chronic hepatitis c (cHC) patients with peginterferon alfa-2a (40KD) and ribavirin
    Zehnter, Elmar
    Mauss, Stefan
    John, Christine
    Heyne, Renate
    Moeller, Berrid
    Lutz, Thomas
    Bokemeyer, Bernd
    Kihn, Robert
    Moog, Gero
    Vornkahl, Heike
    Alshuth, Ulrich
    Hueppe, Dietrich
    GASTROENTEROLOGY, 2006, 130 (04) : A839 - A839
  • [28] Clinical and persistency outcomes in hepatitis C patients treated with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, T. I.
    Ye, X.
    Blumentals, W. A.
    Brixner, D. I.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S295 - S296
  • [29] TELAPREVIR, PEGINTERFERON ALFA-2A AND RIBAVIRIN IMPROVED RATES OF SUSTAINED VIROLOGIC RESPONSE (SVR) IN "DIFFICULT-TO-CURE" PATIENTS WITH CHRONIC HEPATITIS C (CHC): A POOLED ANALYSIS FROM THE PROVE1 AND PROVE2 TRIALS
    Everson, Gregory T.
    Dusheiko, Geoffrey M.
    Ferenci, Peter
    Alves, Katia
    Bengtsson, Leif
    McNair, Lindsay
    McHutchison, John G.
    Muir, Andrew
    Pawlotsky, Jeon-Michel
    Zeuzem, Stefan
    HEPATOLOGY, 2009, 50 (04) : 1025A - 1025A
  • [30] PREDICTIVE FACTORS OF THROMBOCYTOPENIA IN TREATMENT OF CHRONIC HEPATITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN
    Mauss, S.
    Schober, A.
    Lutz, T.
    Moog, G.
    Schuchmann, M.
    Heyne, R.
    John, C.
    Schiffelholz, W.
    Baumgarten, A.
    Hey, K. -H.
    Eisenbach, C.
    Teuber, G.
    Schmidt, W.
    Bruch, H. -R.
    Geyer, P.
    Alshuth, U.
    Hueppe, D.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S185 - S185
12345